Vanda Pharmaceuticals Announces Participation at September 2026 Investor Conferences

Vanda Pharmaceuticals schedules multiple September 2026 healthcare investor conference appearances, with select presentations available via live and archived webcasts.

Rhea-AI Summary

Vanda Pharmaceuticals (VNDA) will participate in four investor conferences in September 2026, including events hosted by Wells Fargo, Cantor, H.C. Wainwright and Morgan Stanley.

Corporate presentations at the Cantor and H.C. Wainwright conferences will be webcast live and archived for about 30 days on Vanda's website.

Market Context

Pre-headline, VNDA's prior daily close was up 0.37%, while the momentum scanner recorded 3 peers mov...

Analysis

Pre-headline, VNDA's prior daily close was up 0.37%, while the momentum scanner recorded 3 peers moving down. That divergence adds context to a conference schedule; the active S-3 shelf remains a financing risk to monitor.

Key Figures

Wells Fargo conference date: September 8, 2026 Cantor conference date: September 11, 2026 Cantor presentation time: 8 a.m. Eastern Time +4 more

7 metrics

Wells Fargo conference date September 8, 2026 21st Annual Healthcare Conference

Cantor conference date September 11, 2026 2026 Global Healthcare Conference

Cantor presentation time 8 a.m. Eastern Time 2026 Global Healthcare Conference

H.C. Wainwright conference date September 15, 2026 28th Annual Global Investment Conference

H.C. Wainwright presentation time 10 a.m. Eastern Time 28th Annual Global Investment Conference

Morgan Stanley conference date September 16, 2026 24th Annual Global Healthcare Conference

Archive availability approximately 30 days Archived conference availability on Vanda's website

Historical Context

5 past events · Latest: Aug 24 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Aug 24	Orphan designation	Positive	+0.9%	European Commission granted orphan designation for imsidolimab in generalized pustular psoriasis.
Aug 5	Quarterly earnings	Negative	+0.5%	Sales declined year over year while quarterly losses widened despite reiterated revenue guidance.
Jul 29	Earnings scheduling	Neutral	+2.6%	Vanda scheduled its second-quarter financial-results release and conference call for August 5.
Jul 16	Orphan designation	Positive	-0.2%	EMA committee issued a positive opinion recommending orphan designation for imsidolimab.
Jul 15	Partnership announcement	Positive	-6.8%	NEREUS sponsorship partnership was announced with the No. 47 IndyCar entry.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Historical reactions were mixed: regulatory news ranged from +0.95% to -0.18%, while the NEREUS sponsorship announcement was followed by -6.84%.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WASHINGTON, Sept. 2, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate at the following upcoming investor conferences in September 2026:

The Wells Fargo 21^st Annual Healthcare Conference in Boston on Tuesday, September 8, 2026.

The 2026 Cantor Global Healthcare Conference in New York City on Friday, September 11, 2026. A corporate presentation is scheduled for 8 a.m. Eastern Time.

The H.C. Wainwright 28^th Annual Global Investment Conference in New York City on Tuesday September 15, 2026. A corporate presentation is scheduled for 10 a.m. Eastern Time.

The Morgan Stanley 24^th Annual Global Healthcare Conference in New York City on Wednesday, September 16, 2026.

The corporate presentations given at the 2026 Cantor Global Healthcare Conference and H.C. Wainwright 28^th Annual Global Investment Conference may be accessed live on Vanda's corporate website, www.vandapharma.com. Investors should click on the Investors tab and follow the link under Recent Events. Investors are advised to go to the conference website at least 15 minutes early to register, download, and install any necessary software or presentations. A link to the archived conference will be available on Vanda's website for a period of approximately 30 days.

About Vanda Pharmaceuticals Inc.

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.

Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com

Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-september-2026-investor-conferences-302868188.html

SOURCE Vanda Pharmaceuticals Inc.

FAQ

Which investor conferences will Vanda Pharmaceuticals (VNDA) attend in September 2026?

Vanda will attend the Wells Fargo 21st Annual Healthcare Conference in Boston on September 8, the 2026 Cantor Global Healthcare Conference on September 11, the H.C. Wainwright 28th Annual Global Investment Conference on September 15, and the Morgan Stanley 24th Annual Global Healthcare Conference on September 16.

When are Vanda Pharmaceuticals (VNDA) corporate presentations scheduled during the September 2026 conferences?

Vanda has a corporate presentation at the 2026 Cantor Global Healthcare Conference on Friday, September 11, 2026, at 8 a.m. Eastern Time, and another at the H.C. Wainwright 28th Annual Global Investment Conference on Tuesday, September 15, 2026, at 10 a.m. Eastern Time.

How can investors access the Vanda Pharmaceuticals (VNDA) webcasts for the September 2026 conferences?

Live webcasts of Vanda’s presentations at the 2026 Cantor Global Healthcare Conference and the H.C. Wainwright 28th Annual Global Investment Conference may be accessed via the Investors tab on www.vandapharma.com, under the Recent Events link.

Will replays of Vanda Pharmaceuticals (VNDA) September 2026 conference presentations be available?

Yes. A link to the archived conference presentations will be available on Vanda’s website for approximately 30 days after the events, allowing investors to view the webcasts on demand during that period.

What should investors do before joining the Vanda Pharmaceuticals (VNDA) September 2026 webcasts?

Investors are advised to visit the conference website at least 15 minutes early to register and to download and install any required software or presentation materials needed to access the live webcast smoothly.